SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001513162-19-000013
Filing Date
2019-01-10
Accepted
2019-01-10 16:44:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A schedule_13da.htm SC 13D/A 37739
  Complete submission text file 0001513162-19-000013.txt   39205
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Subject) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: SC 13D/A | Act: 34 | File No.: 005-36989 | Film No.: 19520649
SIC: 8071 Services-Medical Laboratories

Mailing Address C/O ACACIA RESEARCH CORPORATION 500 NEWPORT CENTER DRIVE, 7TH FLOOR NEWPORT BEACH CA 92660
Business Address
KUMAR AMIT (Filed by) CIK: 0001191905 (see all company filings)

Type: SC 13D/A